NEW YORK (TheStreet) -- CHANGE IN RATINGS

Accenture ( ACN) was upgraded to Outperform at Wells Fargo. Visibility is improving, and business fundamentals appear to have reached an inflection point.

Archer-Daniels Midland ( ADM) was downgraded to Market Perform at BMO Capital. Valuation call, based on a $36 price target.

Beacon Roofing ( BECN) was downgraded from Outperform to Neutral at Robert Baird. $16 price target. Shingle pricing has turned negative.

ConocoPhillips ( COP) was downgraded to Underweight at Morgan Stanley. Valuation call, based on a $56 price target.

Deere ( DE) was downgraded to Market Perform at Wells Fargo. Company is not likely to raise guidance above current consensus expectations.

Amdocs ( DOX) was started with a Hold rating at ThinkEquity. $30 price target. Future growth will most likely be driven by acquisitions.

Idacorp ( IDA) was upgraded from Hold to Buy at Keybanc. $38.50 price target. Two tax deductions will benefit equity value.

Limited Brands ( LTD) was downgraded to Sell at Goldman Sachs. $24 price target. Company faces earnings headwinds in 2011.

Norfolk Southern ( NSC) was downgraded to Market Perform at Wells Fargo. Valuation call, as coal demand could wane.

Rubicon Technology ( RBCN) was initiated with a Sell rating at Merriman, Curhan Ford. Supply has caught up to demand in LCD lighting.

The Hanover Insurance Group ( THG) was downgraded to Equal Weight from Overweight at Barclays. Less earnings power and reduced ROE improvement, Barclays said. Price target cut to $46 from $49.

Walgreen ( WAG) was upgraded from Equal-Weight to Overweight at Morgan Stanley. $40 price target. Company faces easy comparisons for the flu season.

Wright Medical ( WMGI) was downgraded from Outperform to Neutral at Robert Baird. $17 price target. Company could struggle to achieve consensus earnings expectations.

Xilinx ( XLNX) was downgraded from Neutral to Sell at Goldman Sachs. Estimates were also cut, as cyclical pressures could hurt earnings. $22 price target.

STOCK COMMENTS / EPS CHANGES

Accenture 2011 and 2012 estimates boosted to $3.03 and $3.46, respectively, at Credit Suisse. Banking on enterprise spend recovery, Credit Suisse said. Maintain Outperform rating and $55 price target.

Accenture estimates, target increased at Citigroup. Estimates were raised through 2012. Company had a good quarter and boosted guidance. Buy rating and new $53 price target.

Altera ( ALTR) estimates, target reduced at Goldman. Estimates were cut through 2012, Goldman Sachs said. Company faces cyclical headwinds. Neutral rating and new $26 price target.

Covance ( CVD) estimates, target boosted at Jefferies. Shares now seen reaching $54, according to Jefferies. Estimates also upped, given the new $2.2 billion contract from SNY. Buy rating.

EMC ( EMC) price target raised at Barclays. EMC shares now seen reaching $28, up from $26, as pure-play storage vendors are positioned well for growth, Barclays said. Maintain Overweight rating.

Goldman Sachs ( GS) target, estimates cut at Credit Suisse. Price target trimmed to $190 from $200. Expecting weak third-quarter results and Basel/capital to be a focus, Credit Suisse said. 2010 EPS estimate reduced to $14.4, 2011 set at $19.00. Reiterate Outperform rating.

H&R Block ( HRB) target lowered at Goldman. Shares now seen reaching $13, according to Goldman Sachs. Company faces increased mortgage risk. Neutral rating and $13 price target.

Incyte ( INCY) target increased to $22 at Oppenheimer. Expect Response trial to be successful. Outperform rating.

Intuit ( INTU) target raised at Morgan Stanley. Shares now seen reaching $51, according to Morgan Stanley. Small business demand is growing. Overweight rating.

Lockheed Martin ( LMT) numbers lowered at UBS. Shares of LMT now seen reaching $71. Estimates also cut, as the company now sees flat sales in 2011. Neutral rating.

Morgan Stanley ( MS) target, estimates lowered at Credit Suisse. Price target reduced to $35 from $37. Expect modestly profitable third-quarter but oversized BV growth, Credit Suisse said. 2010 and 2011 EPS estimates lowered to $2.56 and $3.00, respectively. Maintain Outperform rating.

Noble ( NE) estimates lowered through 2011 at Citigroup. New ship was delayed and the company is facing a higher tax rate this quarter. Buy rating and $36 price target.

Netflix ( NFLX) shares now seen reaching $180, according to Piper Jaffray. Company continues to have multiple growth drivers. Overweight rating.

NetApp ( NTAP) price target boosted to $56 from $40 at Barclays on leading product portfolio that includes NetApp's unified storage architecture. Reiterate Equal Weight rating.

Principal Financial ( PFG) estimates cut through 2011 at UBS. Company is leaving the medical insurance business. Neutral rating and $27 price target.

PPL ( PPL) estimates, target reduced at Morgan Stanley. Shares now seen reaching $31.50, according to Morgan Stanley. Estimates also cut, given a lower rate base in PA. Overweight rating.

This article was written by a staff member of TheStreet.

More from Stocks

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Chart: Goldman Sachs Doesn't See U.S. Economy Falling Apart Anytime Soon

Chart: Goldman Sachs Doesn't See U.S. Economy Falling Apart Anytime Soon

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

What Will GM Do With Cruise -- and Is Its Stock Worth $55?

What Will GM Do With Cruise -- and Is Its Stock Worth $55?